1. Breastfeeding buffers the biological health impacts of low socioeconomic status in children by stabilizing the infant gut microbiota through B. infantis enrichment. ↩︎
  2. Long-read genome and RNA sequencing resolved a complex MEGF8 genotype in a rare Carpenter syndrome type 2 case, underscoring the diagnostic value of emerging sequencing technologies beyond conventional exome sequencing. ↩︎
  3. Prime editing of autologous CD34+ hematopoietic stem cells restored NADPH oxidase activity in two patients with p47-CGD, providing early clinical proof-of-concept for this gene correction approach. ↩︎
  4. Inborn errors of IRF transcription factors produce diverse immune and developmental phenotypes, and their study exemplifies how clinical and translational research together advance both patient care and fundamental human biology. ↩︎
  5. Biallelic germline variants in ASXL1, an epigenetic modifier not previously linked to immune disease, define a novel inborn error of immunity characterised by B cell loss, T cell exhaustion, and susceptibility to viral infections and associated malignancies. ↩︎
  6. A novel STAT6 gain-of-function variant expands the clinical phenotype of this rare disease and reports successful therapeutic management in two patients. ↩︎
  7. A de novo ThPOK variant with complex multimorphic activity causes the first reported human disease linked to this master CD4+ T cell regulator, presenting as T cell deficiency, allergy, interstitial lung disease, and fibrosis. ↩︎
  8. A germline dominant-negative HELIOS (IKZF2) variant underlying ICHAD syndrome drives broad immune dysregulation, including hyperactive CD4+ T cells, aberrant Tregs, and NK cell deficiency, illuminating HELIOS’s role in human immune homeostasis and tolerance. ↩︎
  9. Over 48 single-gene defects can cause primary atopic disorders, and recognising these monogenic allergic diseases, distinct from common polygenic atopy, is critical for accurate diagnosis and targeted treatment. ↩︎
  10. The infant gut microbiome shapes early immune development, and disruptions to its maturation and composition are increasingly linked to the rising prevalence of pediatric allergic disease pointing toward microbiome-targeted prevention and treatment strategies. ↩︎